# Pharmacokinetic Study of IV Artesunate to Treat Children With Severe Malaria

> **NCT05750459** · PHASE4 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 90 (actual)

## Conditions studied

- Plasmodium Falciparum Infection

## Interventions

- **DRUG:** Artesunate

## Key facts

- **NCT ID:** NCT05750459
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-29
- **Primary completion:** 2025-04-01
- **Final completion:** 2025-04-01
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2025-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05750459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05750459, "Pharmacokinetic Study of IV Artesunate to Treat Children With Severe Malaria". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT05750459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*